GSK-3beta controls osteogenesis through regulating Runx2 activity.
Despite accumulated knowledge of various signalings regulating bone formation, the molecular network has not been clarified sufficiently to lead to clinical application. Here we show that heterozygous glycogen synthase kinase-3beta (GSK-3beta)-deficient mice displayed an increased bone formation due...
Saved in:
| Main Authors: | Fumitaka Kugimiya, Hiroshi Kawaguchi, Shinsuke Ohba, Naohiro Kawamura, Makoto Hirata, Hirotaka Chikuda, Yoshiaki Azuma, James R Woodgett, Kozo Nakamura, Ung-il Chung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2007-09-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0000837&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unraveling RUNX2 mutation in a cleidocranial dysplasia patient: Molecular insights into osteogenesis and proteostasis
by: Luca Dalle Carbonare, et al.
Published: (2025-07-01) -
Targeting casein kinase 2 and ubiquitin-specific protease 7 to modulate RUNX2-mediated osteogenesis in chronic kidney disease
by: Haifeng Lan, et al.
Published: (2025-05-01) -
Retraction Note: Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis
by: Huaiguang Chang, et al.
Published: (2025-06-01) -
Novel reporter alleles of GSK-3α and GSK-3β.
by: William B Barrell, et al.
Published: (2012-01-01) -
Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment
by: LL Girshova, et al.
Published: (2016-10-01)